CGTX
USDCognition Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.315
High
$0.315
Low
$0.306
Volume
0.54M
Company Fundamentals
Market Cap
19.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.07M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Dr. James Galvin of the University of Miami to Serve as Lead Investigator First Site Initiated: Banner Sun Health Research Institute PURCHASE, N.Y., June 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc.,
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics with a Buy and lowers the price target from $5 to $3.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.